Adar Poonawala, Chief Executive Office of Serum Institute, and Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech, on Tuesday communicated their intention to develop, manufacture and supply the Covid-19 vaccines for India and globally.
Also read: No ban on export of vaccines: India
They said the more important task in front of them is saving the lives and livelihoods of populations in India and the world in a joint statement.
Vaccines are a global public health good and they have the power to save lives and accelerate the return to economic normalcy at the earliest.
Also read: Vaccination campaign picks up speed around the world
Now that two Covid-19 vaccines have been issued EUA (emergency use authorization) in India, the focus is on manufacturing, supply and distribution, such that populations that need it the most receive high quality, safe and efficacious vaccines. "Both our companies are fully engaged in this activity and consider it our duty to the nation and the world at large to ensure a smooth rollout of vaccines," they said.
Also read:India announces two-day dry run of Covid immunisation drive
"We are fully aware of the importance of vaccines for people and countries alike, we hereby communicate our joint pledge to provide global access for our Covid-19 vaccines," they added.